デフォルト表紙
市場調査レポート
商品コード
1646734

アラキドン酸の世界市場

Arachidonic Acid

出版日
ページ情報
英文 323 Pages
納期
即日から翌営業日
適宜更新あり
アラキドン酸の世界市場
出版日: 2025年01月31日
発行: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
ページ情報: 英文 323 Pages
納期: 即日から翌営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

アラキドン酸の世界市場は2030年までに4億1,320万米ドルに達する見込み

2024年に2億9,460万米ドルと推定されるアラキドン酸の世界市場は、2024年から2030年にかけてCAGR 5.8%で成長し、2030年には4億1,320万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである粉末アラキドン酸は、CAGR 6.0％を記録し、分析期間終了時には3億2,200万米ドルに達すると予測されています。リキッドアラキドン酸セグメントの成長率は、分析期間中CAGR 5.1%と推定されます。

米国市場は7,690万米ドルと推定、中国はCAGR 8.6％で成長予測

米国のアラキドン酸市場は、2024年に7,690万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけてCAGR 8.6%で推移し、2030年には予測市場規模9,410万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.9%と5.5%と予測されています。欧州では、ドイツがCAGR 3.4%で成長すると予測されています。

世界のアラキドン酸市場- 主要動向と促進要因まとめ

アラキドン酸とは何か、なぜ重要なのか？

アラキドン酸（ARA）は多価不飽和オメガ6脂肪酸で、人体、特に炎症反応と細胞シグナル伝達プロセスにおいて重要な役割を果たしています。細胞膜の主要成分であり、プロスタグランジン、トロンボキサン、ロイコトリエンの合成前駆体として機能し、血液凝固、免疫反応、血圧調節など様々な生理機能に関与しています。ARAは主に肉、卵、魚などの動物性食品に含まれるが、もう一つのオメガ6脂肪酸であるリノール酸からも合成できます。ARAは母乳の重要な成分であり、乳幼児の脳と神経系の開発に不可欠であることから、最近の動向では、乳幼児の栄養における役割が注目されています。全身の健康維持におけるARAの重要性と、成長と発達における重要な働きから、様々な栄養補助食品や強化食品に配合されるようになりました。

アラキドン酸は栄養食品や医薬品にどのように使用されていますか？

アラキドン酸の栄養・医薬品への使用は、その健康効果への意識の高まりとオメガ6脂肪酸サプリメントへの需要の増加により、大幅に拡大しています。乳児用調製粉乳業界では、ARAはしばしばオメガ3脂肪酸のドコサヘキサエン酸（DHA）と組み合わされ、母乳の組成を模倣し、乳児の認知や視覚の発達をサポートします。この組み合わせは、世界中の多くの乳児用調製粉乳の標準成分となっています。乳幼児の栄養摂取にとどまらず、ARAは成人を対象とした栄養補助食品、特に脳の健康、認知機能、運動能力に重点を置いた栄養補助食品にも配合されています。医薬品分野では、ARAは炎症性疾患、自己免疫疾患、心臓血管の健康管理など、潜在的な治療への応用が検討されています。生物活性化合物としてのARAの多用途性により、ARAは幅広い健康製品の貴重な成分となっており、現在進行中の調査により、新たな用途や利点が発見され続けています。

アラキドン酸市場の主な動向と発展は？

いくつかの主な動向と発展がアラキドン酸市場を形成しており、消費者のニーズと嗜好の進化、バイオテクノロジーの進歩を反映しています。最も重要な動向の一つは、動物由来製品に代わるベジタリアンやビーガン向けの需要の高まりにより、植物由来や微生物由来のARAへの注目が高まっていることです。発酵技術の進歩により、非動物由来のARAの生産が可能になり、より幅広い消費者がARAを利用できるようになった。もう一つの重要な動向は、ARA生産の純度と持続可能性が重視されるようになっていることで、メーカーは環境に優しいプロセスを採用し、製品が厳しい品質基準を満たすようにしています。さらに、DHAなど他の生物活性化合物と組み合わせた場合のARAの相乗効果への関心が高まっており、革新的な栄養・治療製品の開発につながっています。こうした動向は、ARA市場を拡大させるだけでなく、メーカー間の技術革新や差別化をも促進しています。

アラキドン酸市場の成長を促す要因は何か？

アラキドン酸市場の開拓は、技術の進歩、消費者行動、規制の進展と密接に結びついたいくつかの要因によって推進されています。第一に、乳児栄養、特に脳と目の開拓におけるARAの重要性に対する認識の高まりが、特に乳児栄養が重要な関心事である新興国市場において、ARAを強化した乳児用調製粉乳の需要を促進しています。第二に、認知健康、炎症管理、運動能力向上のためにサプリメントを求める健康志向の消費者の増加が、成人用栄養補助食品におけるARA市場を拡大しています。第三に、バイオテクノロジーの進歩、特に持続可能な非動物由来のARAの生産が、ベジタリアンやビーガンを含む多様な消費者層にとってARAをより利用しやすいものにしています。さらに、食品や医薬品へのARAの使用に対する規制上の支持と、慢性炎症疾患の有病率の増加が相まって、様々な分野でARAの採用が進んでいます。これらの要因は、ARAの健康上の利点に関する継続的な調査と相まって、ARAを現代の栄養とヘルスケアにおける重要な要素として位置づけ、ARA市場の力強い成長に拍車をかけています。

セグメント

形態（粉末、液体）;用途（乳児用調製粉乳、その他の用途）

調査対象企業の例（全41件）

  • Abcam PLC
  • Ackerlon Co. Pte. Ltd.
  • Acme Synthetic Chemicals
  • Ataman Kimya A.S.
  • Biorbyt
  • Cabio
  • Cambridge Isotope Laboratories, Inc.（CIL）
  • Cayman Chemical Company
  • Enzo Life Sciences, Inc.
  • Laurent Pharmaceuticals, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP10358

Global Arachidonic Acid Market to Reach US$413.2 Million by 2030

The global market for Arachidonic Acid estimated at US$294.6 Million in the year 2024, is expected to reach US$413.2 Million by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Powdered Arachidonic Acid, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$322.0 Million by the end of the analysis period. Growth in the Liquid Arachidonic Acid segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$76.9 Million While China is Forecast to Grow at 8.6% CAGR

The Arachidonic Acid market in the U.S. is estimated at US$76.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$94.1 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Arachidonic Acid Market - Key Trends and Drivers Summarized

What Is Arachidonic Acid and Why Is It Important?

Arachidonic acid (ARA) is a polyunsaturated omega-6 fatty acid that plays a crucial role in the human body, particularly in the inflammatory response and cellular signaling processes. It is a key component of cell membranes and serves as a precursor for the synthesis of prostaglandins, thromboxanes, and leukotrienes, which are involved in various physiological functions such as blood clotting, immune response, and the regulation of blood pressure. ARA is predominantly found in animal-based foods, including meat, eggs, and fish, but it can also be synthesized from linoleic acid, another omega-6 fatty acid. In recent years, ARA has gained significant attention for its role in infant nutrition, as it is a vital component of breast milk and is crucial for the development of the brain and nervous system in infants. The importance of ARA in maintaining overall health and its critical function in growth and development has led to its inclusion in various dietary supplements and fortified foods.

How Is Arachidonic Acid Used in Nutritional and Pharmaceutical Products?

The use of arachidonic acid in nutritional and pharmaceutical products has expanded significantly, driven by growing awareness of its health benefits and the increasing demand for omega-6 fatty acid supplements. In the infant formula industry, ARA is often paired with docosahexaenoic acid (DHA), an omega-3 fatty acid, to mimic the composition of breast milk and support cognitive and visual development in infants. This combination has become a standard ingredient in many infant formulas worldwide. Beyond infant nutrition, ARA is also being incorporated into dietary supplements aimed at adults, particularly those focused on brain health, cognitive function, and athletic performance. In the pharmaceutical sector, ARA is being explored for its potential therapeutic applications, including its role in managing inflammatory conditions, autoimmune diseases, and cardiovascular health. The versatility of ARA as a bioactive compound has made it a valuable ingredient in a wide range of health products, and ongoing research continues to uncover new applications and benefits.

What Are the Key Trends and Developments in the Arachidonic Acid Market?

Several key trends and developments are shaping the arachidonic acid market, reflecting the evolving needs and preferences of consumers and advancements in biotechnology. One of the most significant trends is the increasing focus on plant-based and microbial sources of ARA, driven by the rising demand for vegetarian and vegan alternatives to animal-derived products. Advances in fermentation technology have enabled the production of ARA from non-animal sources, making it more accessible to a broader range of consumers. Another important trend is the growing emphasis on the purity and sustainability of ARA production, with manufacturers adopting environmentally friendly processes and ensuring that their products meet stringent quality standards. Additionally, there is a growing interest in the synergistic effects of ARA when combined with other bioactive compounds, such as DHA, leading to the development of innovative nutritional and therapeutic products. These trends are not only expanding the market for ARA but also driving innovation and differentiation among manufacturers.

What Factors Are Driving Growth in the Arachidonic Acid Market?

The growth in the arachidonic acid market is driven by several factors that are closely aligned with technological advancements, consumer behavior, and regulatory developments. Firstly, the increasing awareness of the importance of ARA in infant nutrition, particularly in brain and eye development, is propelling demand for ARA-enriched infant formulas, especially in emerging markets where infant nutrition is a critical concern. Secondly, the rise in health-conscious consumers seeking supplements for cognitive health, inflammation management, and athletic performance is expanding the market for ARA in adult dietary supplements. Thirdly, advancements in biotechnology, particularly in the production of ARA from sustainable and non-animal sources, are making ARA more accessible to a diverse consumer base, including vegetarians and vegans. Additionally, regulatory support for the use of ARA in food and pharmaceutical products, combined with the increasing prevalence of chronic inflammatory conditions, is driving the adoption of ARA across various sectors. These factors, coupled with ongoing research into the health benefits of ARA, are fueling the robust growth of the arachidonic acid market, positioning it as a critical component of modern nutrition and healthcare.

SCOPE OF STUDY:

The report analyzes the Arachidonic Acid market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Form (Powder, Liquid); Application (Infant Formula, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Abcam PLC
  • Ackerlon Co. Pte. Ltd.
  • Acme Synthetic Chemicals
  • Ataman Kimya A.S.
  • Biorbyt
  • Cabio
  • Cambridge Isotope Laboratories, Inc. (CIL)
  • Cayman Chemical Company
  • Enzo Life Sciences, Inc.
  • Laurent Pharmaceuticals, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Arachidonic Acid - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness of Arachidonic Acid's Role in Infant Nutrition Spurs Market Growth
    • Advancements in Fermentation Technology Expand Addressable Market for ARA
    • Growing Demand for Cognitive Health Supplements Drives ARA Adoption
    • Plant-Based and Microbial Sources of ARA Are Revolutionizing the Market
    • Synergistic Formulations of ARA with DHA Propel Growth in Nutritional Products
    • Expansion of ARA Use in Pharmaceuticals Drives Demand for Therapeutic Applications
    • Here's the Story: How ARA Is Gaining Traction in Sports Nutrition
    • Rising Consumer Preference for Natural and Bioactive Ingredients Drives ARA Market
    • Increasing Prevalence of Chronic Inflammatory Conditions Spurs ARA Demand
    • Growing Adoption of ARA in Functional Foods and Beverages Expands Market Reach
    • Here's How Biotechnology Innovations Are Shaping ARA Production
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Arachidonic Acid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Arachidonic Acid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Arachidonic Acid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Infant formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Infant formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Infant formula by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Arachidonic Acid Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Powder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Powder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Powder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Liquid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Arachidonic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Arachidonic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Arachidonic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: China 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Arachidonic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Arachidonic Acid by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Arachidonic Acid by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Europe 15-Year Perspective for Arachidonic Acid by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Arachidonic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Arachidonic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Germany 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Italy 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Arachidonic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: UK 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Spain 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Russia 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Arachidonic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Arachidonic Acid by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Arachidonic Acid by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Arachidonic Acid by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Arachidonic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Australia 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Arachidonic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: India 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: South Korea 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Arachidonic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Arachidonic Acid by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Arachidonic Acid by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Latin America 15-Year Perspective for Arachidonic Acid by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Argentina 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Brazil 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Mexico 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Latin America 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Arachidonic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Arachidonic Acid by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Arachidonic Acid by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Middle East 15-Year Perspective for Arachidonic Acid by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Iran 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Israel 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Saudi Arabia 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: UAE 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Middle East 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Arachidonic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Arachidonic Acid by Form - Powder and Liquid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Arachidonic Acid by Form - Powder and Liquid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Africa 15-Year Perspective for Arachidonic Acid by Form - Percentage Breakdown of Value Sales for Powder and Liquid for the Years 2015, 2025 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Arachidonic Acid by Application - Infant formula and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Arachidonic Acid by Application - Infant formula and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Arachidonic Acid by Application - Percentage Breakdown of Value Sales for Infant formula and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION